re: new license in nsw and vic rm - would not in the least bit surprise me if this all was to be released within the forthcoming annual and preliminary annual reportCR8
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%